Search for: "TEVA PHARMACEUTICALS USA, INC." Results 101 - 120 of 482
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Dec 2018, 9:00 am by Andrew Hamm
Teva Pharmaceuticals USA Inc. [read post]
27 Nov 2018, 9:30 am by Ronald Mann
Teva Pharmaceuticals USA Inc. presents the next one of those cases. [read post]
23 Nov 2018, 8:03 pm by Patent Docs
Teva Pharmaceuticals USA Inc. case beginning at 4:00 pm (Eastern) on December 4, 2018 at the American University Washington College of Law in Washington, DC. [read post]
17 Oct 2018, 7:49 pm by Brian Craig
The Federal Circuit found the district court committed no error in construing claim terms as non-limiting for nonobviousness purposes or in invalidating as obvious all asserted claims of the Copaxone patents, including a 40-milligram dosage three times per week (Teva Pharmaceuticals USA, Inc. v. [read post]
15 Oct 2018, 7:05 am by Deborah Heller
This week the Court released the calendar for arguments at the end of November and into December these cases are: Apple, Inc. v. [read post]
12 Oct 2018, 1:24 pm by Lawrence B. Ebert
Delaware of invalidity of claims:Plaintiffs-Appellants Teva Pharmaceuticals USA,Inc., Teva Pharmaceutical Industries, Ltd., Teva Neuroscience,Inc., and Yeda Research and Development Co. [read post]
17 Sep 2018, 6:48 am by Law Offices of Jeffrey S. Glassman
(Torrent), Teva Pharmaceuticals (labeled as Major Pharmaceuticals), Teva Pharmaceuticals USA (labeled as Actavis), and Torrent Pharmaceuticals Limited. [read post]
10 Sep 2018, 10:17 am by Lawrence B. Ebert
Roxane was that Acorda lost:Roxane Laboratories, Inc.; Mylan Pharmaceuticals,Inc.; and Teva Pharmaceuticals USA, Inc., have submittedAbbreviated New Drug Applications seeking FDAapproval to market generic versions of Ampyra. [read post]
26 Aug 2018, 4:35 am by Steve Brachmann
Teva Pharmaceuticals USA Inc., on appeal from the Federal Circuit. [read post]
8 Aug 2018, 1:51 pm by Adam Feldman
The current Supreme Court is friendly toward big business. [read post]
23 Jul 2018, 2:38 pm by Jason Rantanen
Mylan Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc., AKORN, Inc. [read post]
23 Jul 2018, 12:05 pm by Dennis Crouch
Teva Pharmaceuticals USA, Inc., et al., No. 17-1229. [read post]
22 Jul 2018, 8:32 pm by Patent Docs
IPR2016-01127, IPR2016-01128, IPR2016-01129, IPR2016-01130, IPR2016-01131, and IPR2016-01132 (and parallel IPRs filed by Petitioners Teva Pharmaceuticals USA, Inc. and Akorn, Inc., which had... [read post]
18 Jul 2018, 11:23 am by Tryn T. Stimart and Jean E. Dassie
Teva Pharmaceuticals USA, Inc., a case with broad implications for the pharmaceutical industry. [read post]
13 Jul 2018, 5:48 pm by Lawrence B. Ebert
Teva Pharmaceuticals USA, Inc., is apertinent intervening case, but did not explain how it isan intervening change in law to the inherency doctrine,especially given that it is an on-sale bar case. 855 F.3d1356 (Fed. [read post]